Advertisement
Screener

CRONOS GROUP INC. (CRON) Restructuring Charges

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Restructuring Charges

CRONOS GROUP INC. (CRON) reported Restructuring Charges of $308.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2026-08-06

  • CRONOS GROUP INC. restructuring charges for the quarter ending 2026-06-30 was $308.00K, a 59.90% decline year-over-year.
  • CRONOS GROUP INC. restructuring charges for the quarter ending 2026-03-31 was $484.00K, a 12.79% decline year-over-year.
  • CRONOS GROUP INC. restructuring charges for the quarter ending 2025-12-31 was $502.00K.
  • CRONOS GROUP INC. restructuring charges for the quarter ending 2025-09-30 was $212.00K.
  • CRONOS GROUP INC. restructuring charges for fiscal 2025 was $2.04M, a 223.33% increase from fiscal 2024.
  • CRONOS GROUP INC. restructuring charges for fiscal 2024 was $630.00K, a 58.66% decline from fiscal 2023.
  • CRONOS GROUP INC. restructuring charges for fiscal 2023 was $1.52M, a 57.01% decline from fiscal 2022.
  • CRONOS GROUP INC. restructuring charges for fiscal 2022 was $3.54M.
Period endRestructuring Charges 3 monthRestructuring Charges 6 monthRestructuring Charges 9 monthRestructuring Charges 12 monthRestructuring Charges 12 month as first filed
2026-06-30$308.00K
10-Q · filed 2026-08-06
$792.00K
10-Q · filed 2026-08-06
$1.29M
derived: sum of 3 quarters · filed 2026-08-06
$1.51M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$484.00K
10-Q · filed 2026-05-11
$986.00K
derived: sum of 2 quarters · filed 2026-05-11
$1.20M
derived: sum of 3 quarters · filed 2026-05-11
$1.97M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$502.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$714.00K
derived: sum of 2 quarters · filed 2026-02-26
$1.48M
derived: sum of 3 quarters · filed 2026-08-06
$2.04M
10-K · filed 2026-02-26
2025-09-30$212.00K
10-Q · filed 2025-11-06
$980.00K
derived: sum of 2 quarters · filed 2026-08-06
$1.53M
10-Q · filed 2025-11-06
$1.53M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$768.00K
10-Q · filed 2026-08-06
$1.32M
10-Q · filed 2026-08-06
$1.32M
derived: sum of 3 quarters · filed 2026-08-06
$1.32M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$555.00K
10-Q · filed 2026-05-11
$555.00K
derived: sum of 2 quarters · filed 2026-05-11
$555.00K
derived: sum of 3 quarters · filed 2026-05-11
$1.10M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$547.00K
derived: sum of 3 quarters · filed 2026-02-26
$630.00K
10-K · filed 2026-02-26
2024-09-30$0.00
10-Q · filed 2025-11-06
$547.00K
derived: sum of 2 quarters · filed 2025-11-06
$630.00K
10-Q · filed 2025-11-06
$731.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$547.00K
10-Q · filed 2025-08-07
$630.00K
10-Q · filed 2025-08-07
$731.00K
derived: sum of 3 quarters · filed 2026-02-26
$2.15M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$83.00K
10-Q · filed 2025-05-08
$184.00K
derived: sum of 2 quarters · filed 2026-02-26
$1.61M
derived: sum of 3 quarters · filed 2026-02-26
$1.61M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$101.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$1.52M
derived: sum of 2 quarters · filed 2026-02-26
$1.52M
derived: sum of 3 quarters · filed 2026-02-26
$1.52M
10-K · filed 2026-02-26
2023-09-30$1.42M
10-Q · filed 2024-11-12
$1.42M
derived: sum of 2 quarters · filed 2024-11-12
$1.42M
10-Q · filed 2024-11-12
2023-06-30$0.00
10-Q · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
2023-03-31$0.00
10-Q · filed 2024-05-09
2022-12-31$3.54M
10-K · filed 2025-02-27
2021-12-31-$3.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$3.26M
derived: sum of 2 quarters · filed 2022-03-01
-$501.00K
derived: sum of 3 quarters · filed 2022-03-01
$0.00
10-K · filed 2022-03-01
2021-09-30$542.00K
10-Q · filed 2022-02-18
$3.30M
derived: sum of 2 quarters · filed 2022-02-18
$3.80M
10-Q · filed 2022-02-18
$3.80M
derived: sum of 4 quarters · filed 2022-03-01
2021-06-30$2.76M
10-Q/A · filed 2022-02-18
$3.26M
10-Q/A · filed 2022-02-18
$3.26M
derived: sum of 3 quarters · filed 2022-03-01
2021-03-31$501.00K
derived: 10-K 12 month − 3 quarters · filed 2022-03-01
$501.00K
derived: sum of 2 quarters · filed 2022-03-01
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
10-K · filed 2022-03-01
2020-09-30$0.00
10-Q · filed 2022-02-18
2019-12-31$5.33M
10-K · filed 2022-03-01
$889.00K
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87